Drug Manufacturers Under Consideration – WCRX, TEVA, AMRN, DVAX
Houston, TX –February 11, 2013 — (Net PR News) – AnotherWinningTrade.com, the leader for breaking information and up-to-date market activities on Wall Street, locates high-growth equity opportunities. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.
Today’s focus is on: NASDAQ:WCRX, NYSE:TEVA, NASDAQ:AMRN, NASDAQ:DVAX
Warner Chilcott Plc (NASDAQ:WCRX) reported its outlook for full year 2013’s financial results. During full year 2013 total revenue was estimated to be within the range of $2.3 to $2.4 billion.
Warner Chilcott Plc percentage change plunged -1.80% to close at $14.19 with the total traded volume of 8.10 million shares, as compared to average volume of 5.35 million shares.
Is WCRX A Solid Investment At These Levels? Find Out Exactly Where WCRX Is Headed With This TREND ANALYSIS REPORT
WCRX’s total market capitalization is $3.55 billion along with 250.47 million shares outstanding. Its beta value stands at 1.17 points and its earnings per share remained $1.47. The Company’s lowest price during last trade was $14.06 while its highest price was $14.75 for the day.
Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) percentage change increased+1.90% to close at $38.68 with the total traded volume of 7.08 million shares, as compared to average volume of 5.16 million shares.
TEVA’s shares were trading within the range of $38.00-$38.96 while its opening price was $38.30. Its market capitalization is $33.57 billion and EPS was $2.24. If we look at its previous three months trade, it plunged -3.73% while in the last 5 day’s it remained up +2.46%.
Get A Free Report And Detailed Analysis On TEVA CLICK HERE To Read
Amarin Corporation plc (ADR) (NASDAQ:AMRN) unveiled that, in New York City at the Waldorf Astoria, on Wednesday, February 13, 2013, at 4:00 p.m. ET, the company will attend the Leerink Swann Global Healthcare Conference 2013. In this conference, the President of the company, John F. There, has planned to present a general company update.
Amarin Corporation was moving upward during the previous trading session. Amarin Corporation plc (ADR)(NASDAQ:AMRN) reported an upsurge of 0.59% after opening at the price of $8.61, its closing price for the day was $8.58.
Amarin Corporation’s earning per share is $-1.09 while its beta value stands at 1.50 times. The Company’s current market capitalization stands at $1.29 billion along with 149.77 million shares.
How Should Investors React To AMRN Now? Find Out In This TREND ANALYSIS REPORT
The Company’s total trading volume for the day was 1.91 million shares, versus its average volume of 4.06 million shares. If we look at the previous 5 day’s performance of the stock, it remained increasing with the gain of 1.54% and, in its last one month’s trade it plunged -0.46%.
Dynavax Technologies Corporation(NASDAQ:DVAX) reported the increase of +0.95% and closed at $3.19 with the total traded volume of 6.06 million shares. The stock’s opening price was $3.21.
How Should Investors Trade DVAX Now? Don’t Trade DVAX Until You Read This TREND ANALYSIS REPORT
The 52-week price range of the stock remained $2.22 – $5.34, while during last trade its minimum price was $3.11 and it gained its highest price of $3.33. The company has a total of 178.71 million outstanding shares and its total market capitalization is $570.08 million. The Company’s last 5 days shows a uptrend with the rise of +2.57%.
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.